Clinical Trial to Assess Efficacy of cYclosporine Plus Standard of Care in Hospitalized Patients With COVID19

NCT04392531 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

111

Enrollment

OTHER

Sponsor class

Conditions

COVID19 Infection

Interventions

DRUG: Cyclosporine
DRUG: Standard treatment

Sponsor

Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz